U.S. Markets closed

US Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - MedCore

LONDON, March 7, 2017 /PRNewswire/ -- Description

Download the full report: https://www.reportbuyer.com/product/4759856/

General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

Hyaluronic acid products involve one-, two-, three- or five-dose cycles, with the actual number of doses taken often being less than a full treatment. The growth of single-injection products over three- and five-injection products has been the most significant trend in the market. The single-injection has, to some extent, cannibalized other injection types; the convenience of the single-injection procedure has aided market penetration. The introduction of a two injection product in 2016 will further squeeze market share from the three- and five-injection products. Furthermore, viscosupplementation is beginning to be an expected treatment before joint replacement; this will drive unit sales growth.
As of 2016, both the single-injection and triple-injection markets were approximately the same in terms of market value, with the triple-injection being a little larger. While the three-injection market continues its positive growth, the collective hyaluronic acid viscosupplementation market is shifting to single-injection. The single-injection market is expected to become the largest segment of the HA market in the next couple of years because due to ease-of-use.

Osteoarthritis, which is a condition marked by the degeneration of bone joints and cartilage, affected approximately 40 million people in the United States in 2016. Patients who suffer from osteoarthritis experience acute joint pain, tenderness, stiffness, creaking, locking of the joints and inflammation. These symptoms are caused by the degeneration of joint cartilage, subchondral bone and synovial fluid, specifically the polysaccharide hyaluronate. Cartilage and synovial fluid are important for absorbing stress and cushioning joints during normal activity. Progressive deterioration of cartilage and an overactive immune response may also lead to muscle atrophy and chronic disability.

Scope: 2013-2023
Download the full report: https://www.reportbuyer.com/product/4759856/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-market-report-for-orthopedic-hyaluronic-acid-viscosupplementation-2017---medcore-300419884.html